Search Page

1

Cite

Share

TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.

Stephan D, Sbai O, Wen J, Couraud PO, Putterman C, Khrestchatisky M, Desplat-Jégo S. Stephan D, et al. Among authors: khrestchatisky m. J Neuroinflammation. 2013 Jan 15;10:9. doi: 10.1186/1742-2094-10-9. J Neuroinflammation. 2013. PMID: 23320797 Free PMC article.

Cite

Share

2

Cite

Share

Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier.

Molino Y, David M, Varini K, Jabès F, Gaudin N, Fortoul A, Bakloul K, Masse M, Bernard A, Drobecq L, Lécorché P, Temsamani J, Jacquot G, Khrestchatisky M. Molino Y, et al. Among authors: khrestchatisky m. FASEB J. 2017 May;31(5):1807-1827. doi: 10.1096/fj.201600827R. Epub 2017 Jan 20. FASEB J. 2017. PMID: 28108572

We thus provide further evidence that LDLR is a relevant receptor for CNS drug delivery via receptor-mediated transcytosis and that the peptide vectors we developed have the potential to transport drugs, including proteins or Ab based, across the BBB.-Molino, Y., David, M. …

We thus provide further evidence that LDLR is a relevant receptor for CNS drug delivery via receptor-mediated transcytosis and that the pept …

Cite

Share

3

Cite

Share

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017.

Greenwood J, Hammarlund-Udenaes M, Jones HC, Stitt AW, Vandenbroucke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gaillard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M. Greenwood J, et al. Among authors: khrestchatisky m. Fluids Barriers CNS. 2017 Nov 7;14(1):31. doi: 10.1186/s12987-017-0079-9. Fluids Barriers CNS. 2017. PMID: 29110676 Free PMC article.

Cite

Share

4

Cite

Share

gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery.

Iachetta G, Falanga A, Molino Y, Masse M, Jabès F, Mechioukhi Y, Laforgia V, Khrestchatisky M, Galdiero S, Valiante S. Iachetta G, et al. Among authors: khrestchatisky m. Sci Rep. 2019 Jun 24;9(1):9183. doi: 10.1038/s41598-019-45137-8. Sci Rep. 2019. PMID: 31235716 Free PMC article.

Cite

Share

5

Cite

Share

Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells.

Theret L, Jeanne A, Langlois B, Hachet C, David M, Khrestchatisky M, Devy J, Hervé E, Almagro S, Dedieu S. Theret L, et al. Among authors: khrestchatisky m. Oncotarget. 2017 Aug 10;8(45):78614-78632. doi: 10.18632/oncotarget.20201. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108253 Free PMC article.

Cite

Share

6

Cite

Share

Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.

Paumier JM, Py NA, García-González L, Bernard A, Stephan D, Louis L, Checler F, Khrestchatisky M, Baranger K, Rivera S. Paumier JM, et al. Among authors: khrestchatisky m. FASEB J. 2019 Feb;33(2):2910-2927. doi: 10.1096/fj.201801076R. Epub 2018 Oct 17. FASEB J. 2019. PMID: 30332299

These data unveil new mechanistic insights to support the proamyloidogenic role of MT1-MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.-Paumier, J.-M., Py, N. A., Gonzalez, L. G., …

These data unveil new mechanistic insights to support the proamyloidogenic role of MT1-MMP based on APP processing and trafficking, and rein …

Cite

Share

7

Cite

Share

Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.

van Gijsel-Bonnello M, Baranger K, Benech P, Rivera S, Khrestchatisky M, de Reggi M, Gharib B. van Gijsel-Bonnello M, et al. Among authors: khrestchatisky m. PLoS One. 2017 Apr 14;12(4):e0175369. doi: 10.1371/journal.pone.0175369. eCollection 2017. PLoS One. 2017. PMID: 28410378 Free PMC article.

Cite

Share

8

Cite

Share

MT5-MMP, just a new APP processing proteinase in Alzheimer's disease?

Baranger K, Khrestchatisky M, Rivera S. Baranger K, et al. Among authors: khrestchatisky m. J Neuroinflammation. 2016 Jun 28;13(1):167. doi: 10.1186/s12974-016-0633-4. J Neuroinflammation. 2016. PMID: 27349644 Free PMC article.

Cite

Share

9

Cite

Share

MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.

Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, Khrestchatisky M, Rivera S. Baranger K, et al. Among authors: khrestchatisky m. Cell Mol Life Sci. 2016 Jan;73(1):217-36. doi: 10.1007/s00018-015-1992-1. Epub 2015 Jul 23. Cell Mol Life Sci. 2016. PMID: 26202697 Free PMC article.

Cite

Share

10

Cite

Share

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.

Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, Benech P, Féron F. Landel V, et al. Among authors: khrestchatisky m. Mol Neurodegener. 2014 Sep 11;9:33. doi: 10.1186/1750-1326-9-33. Mol Neurodegener. 2014. PMID: 25213090 Free PMC article.

Cite

Share